Harvoni Recent News
Will Merck Encroach On Gilead's Harvoni Territory?
Gilead Trounces Hep C Estimates; Harvoni International Footprint Nearly Equals U.S.
Massachusetts Attorney General To Gilead Sciences: Cost Of Harvoni & Sovaldi Drugs 'May Constitute An Unfair Trade Practice In Violation Of Massachusetts Law'
Gilead Sciences Tumbles; Unconfirmed Reports Of Drug Pricing Changes In Japan
High Drug Prices Put Gilead Under Fire From Senate Committee
Gilead Sciences: Here's What A Bull And A Bear Are Saying
Keep An Eye On These 8 After-Hours Movers
Gilead Still A 'Buy' After Harvoni Approval In Japan, Maxim Proclaims
Gilead Soothes Price War Worry With Q1 Results
Is Gilead Sciences About To Buy Vertex For $45 Billion?
What's Wall Street Been Saying About Gilead Lately?
This Data Offers Insight Into Gilead Sales
Gilead Shares Tumble On Drug Warning; Baird Says Buy
A Look At 3 Biotech Stocks With Upside Potential
UPDATE: Barclays Initiates Coverage On Gilead Sciences, 'Should Remain Ahead Of Its Peers'